News Discussions

What should we consider when discussing payments for those who may have been harmed by vaccines?

A Bill to place a duty on the Secretary of State to review, and publish a report on, the merits of increasing the relevant statutory sum under the Vaccine Damage Payments Act 1979 for all claims since 1 January 2020 by an amount representing the amount of inflation since 2007

What are the potential impacts of recent Senate actions on the future of healthcare policy in our community?

Sen. Bernie Moreno (R-Ohio) isn't giving up on a health care plan that can win 35 Senate Republicans and a majority of Democrats — but he and a small bipartisan group have about three weeks left to find it. Why it matters: Enhanced ACA subsidies have expired, which will raise health care costs for millions of Americans. But key negotiators see a final chance to revive them. "We're on the clock," Moreno told Axios in an interview. "We're not going to talk about this past January — like, we either make a deal this month or we don't make a deal.""It may be we don't make a deal," he acknowledged, given the political atmosphere. He won't push a bill that only gets a handful of Republicans — he wants 35. Zoom in: The bipartisan plan would reinstate the ACA enhanced subsides for two years and extend open enrollment into March, Moreno said, walking through policies that he says have "decent consensus." It will likely include income caps at 700% of the poverty line, replace $0 premium plans with $5 premiums and allow individuals to choose whether the enhanced subsidies go into Health Savings Accounts or directly toward premiums.The group has also discussed massive penalties on insurance companies that deliberately enroll people into Obamacare without their knowledge. What to watch: Cost-sharing reductions are a big part of the talks now too, and would likely go into effect in year two, Moreno said. It could be key for GOP support as they cut government costs and, Moreno argued, would lower Obamacare premiums for everyone by about 11%. The other side: Language ensuring taxpayer dollars do not go toward abortions continues to be sticking point, Moreno acknowledged, though he hopes there can be a break through. "It's not about gaining ground and saying we're doing something more than [the Hyde Amendment]. And it's not something, on the Democrat side, saying we're doing something less than Hyde," he said. "We're trying to respect a established tradition."Trump urged House Republ

How can we share new healthcare ideas quickly during public health emergencies?

This document describes strategies to strengthen the process of sharing and applying emerging knowledge on patient care before and during public health emergencies, focusing on strategies that leaders of professional societies can use

How can we improve treatment options for patients with squamous NSCLC based on recent research findings?

We read with interest the results of the HARMONi-6 trial by Zhiwei Chen and colleagues,1 which showed that ivonescimab plus chemotherapy improved progression-free survival versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (NSCLC). However, PD-L1-based subgroup results reveal a critical stratification signal. In patients with PD-L1 tumour proportion score (TPS) of under 50%, dual blockade achieved marked benefit (hazard ratio [HR] 0·63; 95% CI 0·41–0·98), whereas in patients with PD-L1 TPS of 50% or over, the improvement was numerical but not significant (HR 0·71; 0·37–1·33)

How can modern neuroscience inform public policy to address trauma and fear in communities?

In this Huberman Lab Essentials episode, I explore the neuroscience of fear and trauma and how to effectively process and eliminate traumatic responses. I explain why successful fear treatment requires both extinction of the old fearful response and replacement with a new positive association—not just cognitive reframing. I also explain how the threat reflex activates specific circuits connecting the amygdala, prefrontal cortex, and dopamine systems, and why detailed recounting of traumatic events progressively reduces their physiological impact. Finally, I review evidence-based approaches, including prolonged exposure therapy and cognitive behavioral therapy, discuss how five minutes per day of deliberate stress through cyclic hyperventilation can rewire fear responses, explain the critical role of social connection in activating neural pathways that reduce trauma, and share supplementation options for managing anxiety. Read the episode show notes at hubermanlab.com. Thank you to our sponsors AGZ by AG1: https://drinkagz.com/huberman LMNT: https://drinklmnt.com/huberman Function: https://functionhealth.com/huberman Timestamps (0:00) Introducing Fear & Trauma (0:17) What is Fear? (1:03) Autonomic Arousal: "Alertness" vs. "Calmness" (2:05) Fear vs. Stress & Anxiety (9:20) "The Threat Reflex": Neural Circuits for Fear (20:50) Cognitive (Narrative) Therapies for Fear (26:35) PTSD Treatments: Ketamine, MDMA, Oxytocin (33:11) Deliberate Brief Stress Can Erase Fears & Trauma (35:51) Nutrition, Sleep, & Other General Support Erasing Fear & Trauma (38:18) Recap Disclaimer & Disclosures

What are the potential impacts of the FDA's review on access to abortion pills in Louisiana?

A federal district court on Tuesday paused Louisiana’s lawsuit against the Food and Drug Administration’s liberalization of dispensing rules for the abortion pill mifepristone until the agency is able to complete a safety review, intensifying the conflict between anti-abortion Republicans and the Trump administration. Judge David Joseph of the Western District of Louisiana, who was […]

What steps should communities take to address the rising cases of meningitis?

How should we decide which new drugs get approved for rare diseases?

In today's Readout Newsletter, Denali and Corcept win FDA approvals, Sarepta eyes a rebound, and Allogene progresses with an off-the-shelf CAR-T

What are some ideas for improving Germany's health care system and making it more affordable for everyone?

A special commission has presented a raft of proposals aimed at curbing Germany's spiraling health care costs. But whether the government can impose them is another matter

How should we use updated data to improve public health policies and services?

Infant deaths occurring in the EU by cause and age

What should be done to improve healthcare for newborns in places facing emergencies like Gaza?

More aid has been allowed into Gaza since the ceasefire began three months ago, but the UN says it is nowhere near enough

How should lobbying by pharmaceutical companies influence healthcare decisions and regulations?

Business is booming for Trump-connected lobbying firms as pharma giants see new opportunity to influence the FDA